64
Growth Score in past quarter
pts
Heat Score 64 in past quarter
-6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
913776
this company is a privately held technology licensing company engaged in the commercial application of virology and viral genetics.
- Robert M. Roth Roth: Vice President, Strategic Operations
- Charles M. Rice: Founder & Managing Director
About the Company
Apath is a privately held technology licensing company engaged in the commercial application of virology and viral genetics to assist pharmaceutical companies in discovering and developing therapeutic products for the treatment of viral infections. The current focus of Apath is on hepatitis C virus (HCV). The company also works with other RNA
viruses that are human pathogens, including Influenza, Respiratory Syncytial Virus (RSV) and Hemorrhagic Fever Viruses.